Molecular Markers of Arterial Hypertension in Patients with Normotony, Pre-Hypertension and Hypertension

被引:0
|
作者
V. V. Sherstnev
M. A. Gruden’
E. I. Elistratova
V. P. Karlina
A. V. Kuznetsova
T. V. Ryzhova
V. M. Ryzhov
O. V. Sen’ko
机构
[1] Russian Academy of Medical Sciences,P.K. Anokhin Research Institute of Human Physiology
[2] Hospital No. 170,N.M. Emmanuel Institute of Biochemical Physics
[3] Federal Medical-Biological Agency of Russia,Institute for Advanced Training
[4] Russian Academy of Sciences,A.A. Dorodnitsyn Computing Center
[5] Federal Medical-Biological Agency of Russia,undefined
[6] Russian Academy of Sciences,undefined
来源
Bulletin of Experimental Biology and Medicine | 2015年 / 158卷
关键词
biomarkers; hypertension; pre-hypertension; normotony;
D O I
暂无
中图分类号
学科分类号
摘要
We studied concentrations of angiotensin II, HLDF24 peptide, endothelin proteins, S100B, and autoantibodies to them and serum levels of blood natriuretic peptide in patients with different categories of “normal” arterial BP and hypertension. The relationship between blood levels of the above factors and normotony, pre-hypertension, and hypertension in the examined groups was analyzed. The results suggest that the studied molecular factors can serve as potential predictors of arterial hypertension and used for personalized hypertension risk assessment.
引用
收藏
页码:604 / 606
页数:2
相关论文
共 50 条
  • [1] Molecular Markers of Arterial Hypertension in Patients with Normotony, Pre-Hypertension and Hypertension
    Sherstnev, V. V.
    Gruden', M. A.
    Elistratova, E. I.
    Karlina, V. P.
    Kuznetsova, A. V.
    Ryzhova, T. V.
    Ryzhov, V. M.
    Sen'ko, O. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 158 (05) : 604 - 606
  • [2] Arterial pre-hypertension and hypertension in intracranial versus extracranial cerebrovascular stenosis
    Wang, D.
    Zhou, Y.
    Guo, Y.
    Wang, C.
    Wang, A.
    Jin, Z.
    Gao, X.
    Wu, S.
    Zhao, X.
    Jonas, J. B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (03) : 533 - 539
  • [3] Arterial pre-hypertension in young adults
    Ortiz-Galeano, I.
    Franquelo-Morales, P.
    Notario-Pacheco, B.
    Nieto Rodriguez, J. A.
    Ungria Canete, M. V.
    Martinez-Vizcaino, V.
    REVISTA CLINICA ESPANOLA, 2012, 212 (06): : 287 - 291
  • [4] Progression of Pre-hypertension
    Giles, Thomas D.
    CURRENT HYPERTENSION REPORTS, 2011, 13 (04) : 262 - 264
  • [5] The prevalence of pre-hypertension and hypertension in an iranian urban population
    Khosravi A.
    Emamian M.H.
    Shariati M.
    Hashemi H.
    Fotouhi A.
    High Blood Pressure & Cardiovascular Prevention, 2014, 21 (2) : 127 - 135
  • [6] Pre-hypertension: another 'pseudodisease'?
    Meier, Pascal
    Messerli, Franz H.
    Baumbach, Andreas
    Lansky, Alexandra J.
    BMC MEDICINE, 2013, 11
  • [7] Pre-Hypertension: Rationale for Pharmacotherapy
    Egan, Brent M.
    Laken, Marilyn A.
    CURRENT HYPERTENSION REPORTS, 2013, 15 (06) : 669 - 675
  • [8] Pre-hypertension: Is it an inflammatory state?
    Nandeesha, H.
    Bobby, Zachariah
    Selvaraj, N.
    Rajappa, Medha
    CLINICA CHIMICA ACTA, 2015, 451 : 338 - 342
  • [9] Pre-hypertension: another 'pseudodisease’?
    Pascal Meier
    Franz H Messerli
    Andreas Baumbach
    Alexandra J Lansky
    BMC Medicine, 11
  • [10] Should Pre-hypertension Be Treated?
    Kanegae, Hiroshi
    Oikawa, Takamitsu
    Kario, Kazuomi
    CURRENT HYPERTENSION REPORTS, 2017, 19 (11)